Browse by Author or Creator

Article

1. Machado, L., Jones, L., Divakar, S., Naidoo, M. and Anthony, K. (2025) A unified model for Duchenne muscular dystrophy gene involvement in cancer: context-dependent tumour suppression and oncogenicity. FEBS Open Bio. 16(1), pp. 222-236. 2211-5463.
2. Jones, L., Divakar, S., Collins, L., Hamarneh, W., Ameerally, P., Anthony, K. and Machado, L. (2025) Duchenne muscular dystrophy gene product expression is associated with survival in head and neck squamous cell carcinoma. Scientific Reports. 15(1) 2045-2322.
3. Naidoo, M., Jones, L., Conboy, B., Hamarneh, W., D'Souza, D., Anthony, K. and Machado, L. (2022) Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Scientific Reports. 12(1) 2045-2322.
4. Jones, L., Naidoo, M., Machado, L. and Anthony, K. (2020) The Duchenne muscular dystrophy gene and cancer. Cellular oncology (Dordrecht). 44(1), pp. 19-32. 2211-3428.

Conference or Workshop Item

1. Naidoo, M., Jones, L., Conboy, B., Hamarneh, W., D'Souza, D., Anthony, K. and Machado, L. (2022) Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Poster presented to: Cancer Research UK Brain Tumour Conference, 2022-09-05 - 2022-09-07.

Thesis

1. Jones, L., Machado, L. and Anthony, K. Investigating a Role for the Duchenne Muscular Dystrophy Gene in the Tumourigenesis of Head and Neck Cancer. PhD thesis. University of Northampton.